2m 2m 2m 2m 2m 2m 2m
CRONOS GROUP (CRON)
NASDAQ
$3.43-$0.02 (-0.55%)
Price as of Oct 22, 2026 7:47 PM EDT- $1.2BMarket Cap
- 40.66%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
CRONOS GROUP (CRON)
$3.43-$0.02 (-0.55%)
CRON | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $3.44 | ||
Change | +$0.11 (+3.35%) | ||
Open | $3.39 | ||
High | $3.46 | ||
Low | $3.37 | ||
Previous Close | $3.28 | ||
Volume | 1,146,705 | ||
30-Day Average Volume | 870,601 | ||
1-Week Change | 7.28% | ||
1-Month Change | 1.80% | ||
1-Year Change | 40.66% | ||
3-Year Change | 95.95% | ||
5-Year Change | -43.03% | ||
Fundamentals | |||
Shares Outstanding | 368.5M | ||
Total Assets | $1.2B | ||
Market Cap | $1.2B | ||
Enterprise Value | $782.3M | ||
Period: QTR TTM FY | |||
Revenue | $53.0M | ||
Net Income | $32.1M | ||
Free Cash Flow | $22.3M | ||
EBIT | $32.1M | ||
EBITDA | $35.5M | ||
Net Working Capital | $855.7M | ||
EPS | $0.09 | ||
Enterprise Value/EBITDA | 22 | ||
Enterprise Value/Revenue | 15 | ||
P/B | 1 | ||
P/E | 38 | ||
PEG | 0 | ||
Price/Free Cash Flow | 56 | ||
Price/Operating Cash Flow | 52 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue